ArticleUpdates in surgery2025
Comparative outcomes of patients with esophageal cancer undergoing single-port and four-port thoracoscopic esophagectomy: a single-center experience.
Article in Updates in surgery, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
We aimed to compare the outcomes and postoperative complications of patients with esophageal cancer after single-port thoracoscopic esophagectomy (SPTE) and four-port thoracoscopic esophagectomy (FPTE). We retrospectively collected data from patients who underwent surgery at the First Affiliated Hospital of Kunming Medical University from February 2019 to November 2022. In total, 86 patients were included in the SPTE group and 114 patients were included in the FPTE group. Compared to patients undergoing FPTE, significantly shorter postoperative hospital stay (13.54 ± 3.88 vs. 19.08 ± 5.09 days), shorter chest drainage time (6.06 ± 2.16 vs. 7.45 ± 1.68 days), lower estimated intraoperative blood loss (226.05 ± 94.87 vs. 363.16 ± 78.92 mL), and longer overall length of surgery (346.34 ± 53.86 vs. 332.89 ± 28.86 min) and longer length of abdominal surgery (183.46 ± 33.33 vs. 166.05 ± 22.07 min) were observed among patients undergoing SPTE; however, no significant difference was observed regarding 3-month, 6-month, and 12-month overall survival, time to start oral feeding, and length of thoracic surgery. Furthermore, postoperative intractable pain lasting for 3 months (39.5% vs. 21.0%), pneumonia (34.2% vs. 11.6%), empyema (14.9% vs. 3.5%), and chylothorax (10.5% vs. 2.3%) were significantly more frequent in the FPTE group, whereas postoperative gastrointestinal symptoms (41.9% vs. 23.7%) were significantly more frequent in the SPTE group. There was no significant difference between the groups regarding postoperative arrhythmia, recurrent laryngeal nerve injury, esophagotracheal fistula, second surgery, and intractable pain lasting for 6 and 12 months. Compared to FPTE, SPTE may improve patients' outcomes and prevent some of the major complications.
Indexed as
Identifiers
40549297What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.